PDCD1 and neoplasm: Since this miR is known to enhance T‐cell activation in the tumor microenvironment by blocking the PD‐L1/programmed cell death protein 1 (PD‐1) immune checkpoint,42, 43 it may also play a role in the observed age‐related decrease in tumor immune infiltration.